Bioxytran, Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported net loss was USD 0.785083 million compared to USD 0.91227 million a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.01 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.091 USD | +0.89% |
|
+8.46% | -39.33% |
1st Jan change | Capi. | |
---|---|---|
-39.33% | 16.13M | |
+19.44% | 125B | |
+20.01% | 114B | |
+22.68% | 26.73B | |
-23.72% | 19.43B | |
-17.61% | 16.22B | |
-19.87% | 15.33B | |
+55.81% | 14.2B | |
+8.76% | 14.42B | |
-48.79% | 14.33B |
- Stock Market
- Equities
- BIXT Stock
- News Bioxytran, Inc.
- Bioxytran, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023